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Purpose: This article describes a clinically-diagnosed case of relapsing polychondritis (RP), attended at the Hospital Sao Paulo, and
presents a literature review of the subject. Source of research: The literature review was made via Medline (1990-96), Lilacs (1980-
96), textbooks of rheumatology, and some articles about the history of the disease. In Medline, 113 articles from 1990 to 1996 were
found, and there were 23 articles from 1980 to 1996 in Lilacs. Research procedure: We reviewed the articles available at BIREME
(Biblioteca Regional de Medicina) with the primary focus being on the disease in question. Summary: RP is a rare disease of unknown
etiology described initially by Jackson-Wartenhorst in 1923 and characterized by a recurrent and acute inflammatory process that
causes the collapse of the cartilaginous structures and their subsequent replacement by fibrous connective tissue. The cartilage most
commonly attacked is that of the auricle of the ear and nasal septum, while the cartilage of the trachea, larynx, epiglottis, ribs, and
articulations may also be involved. Ocular inflammations and systemic reactions with fever are also described. In 1976, McAdam
presented a complete prospective study of 23 patients, reviewed the 136 cases described up until that time, and then proposed
diagnostic criteria which were later expanded by Damiani and Levine. Currently, more than 500 cases have been described. Conclusion:
Although a rare disease, better knowledge of it is needed, as RP may be lethal with tracheal collapse and obstruction of respiratory
pathways, making precise diagnosis and adequate therapeutic intervention necessary.
UNITERMS: Relapsing polychondritis.
CASE REPORT
A white Brazilian male, aged 31, fireman, nativeof Terra Boa, Parana, and resident of Poa, SaoPaulo, was interned on July 3, 1996. The patient
came to the hospital with a history of chest pain for one
month.
Eleven months before this, with no prior symptoms,
the patient began to feel stabbing pains localized in the
region between the shoulder blades, which worsened with
movement and physical force. Ten months before
Address for correspondence:
Lincoln Sakiara Miyasaka
Rua Teodoro Sampaio, 972 - casa 18
Sao Paulo/SP - Brasil - CEP 05406-050
internment, pain and redness in the left eye appeared. The
patient then consulted a physician who said it was an
allergy and prescribed prednisone 20 mg. During this
period, the patient received a light trauma to .the nose
which provoked an intense, but painless edema. It was
observed that, with the use of the prescribed medication,
all of the symptoms disappeared, but left as a sequel a
depression in the nose. Two months before internment,
the patient stopped taking the medication and immediately
the pain reappeared in his back at a high intensity, and
also appeared in the wrists and knees. One month before
internment, in addition to the pain in the back, wrists and
knees, the patient began to experience chest pain which
was aggravated by palpation and deep breathing, a daily
fever of 38.5 - 39.0 °C, sweating, chills, lack of appetite,
prostration, weight loss (7 kg in one month, 13 kg total),
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dry cough and dyspnea when coughing. The patient denied
having addictions to tobacco or alcohol.
Physical examination showed the patient to be in
regular general condition, fever (38°C), slimmed, eupneic,
anemic, HR= 94, arterial blood pressure 11/8 cm of Hg.
On his face, a depression in the nose was observed
(photo). A decrease of vesicular murmur in both lungs
without abnormal rale was noted. There was no alteration
in the heart, nor in the abdomen. There was pain in the
articulations of the knees, wrists, and costo-condral
articulations without local heat or redness.
LABORATORY FINDINGS
Creatinin = 0.5 mg/dl; Potassium = 4.5 mEq/l; sodium
= 143 mEq/l; Bilirrubin T= 0.4, D = 0.2, 1= 0.2 GOT = 9
UIl, GPT = 11U/l; Erythrocyte count =4.4 x 10 I mm3;
Hb= 12.2 g/dl; Ht = 38%; MCH = 27.73 pg; MCHC =
32.11 g/dl; MCV = 86.36; platelet = 394,000; leukocyte
= 14,100 (neut = 76, eos = 3, bas = 0, limph = 12, mono =
9); Alb = 3.1 g/dl; Urinalysis: pH = 6.5, D = 1020, prot (-
), gluc(-), leukocytes = 12,000/ml, erythrocytes = 800,0001
ml dismorphism (-), calcium oxalate crystals = few;
calcium = 284 mg in 1,620 ml urine in 20 h; uric acid =
729 mg in 1,620 ml of urine in 20 h.
Antinuclear antibody (-), anti native DNA antibody
(-), anti ENA antibody (U1-RNP, anti-Sm, anti SS-AfRo,
anti-SS-B/La) = (-); CH50 = 188U(130-330); Rheumatoid
factor (-); cryoglobulin (-); anticardiolipin antibody (-);
ANCA (-); C reactive protein = 1/16; LE cels (-);
Mucoprotein = 5.3; anti streptolisin 0< 200 UI/ml; VDRL
(-); urine protein excretion (-); creatinin clearance = 124
ml/min/l.73m; urine culture (-).
Total protein = 6.7 (6-8 g/dl), Alb = 2.91 (3.2 - 5.6);
alpha 1 = 0.21 (0.1 - 0.4); alpha 2 = 1.27 (0.4 - 1.1); beta
= 1.13 (0.1 - 1.2); gamma = 1.18 (0.5 - 1.6); Erythrocyte
Figure - "Saddle" aspect of the nose.
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Table 1
Clinical features in the course of relapsing
polychondritis(6): comparison of 2 series
sedimentation rate = 53 (1-7 mm/h); acid alpha 1
glucoprotein = 395 (43-130 mg/dl).
Prothrombin Time = 80.8 (>70%); RNI = 1.19; PTT
= 1.0 «1.25); Bleeding Time = 1 (1-3 min); coagulation
time = 7 (4-9).
X ray examination of facial bones showed the nasal
bone without alteration, and cartilage hipoplasia.
Ophthalmologic examination showed episcleritis in the
left eye.
Renal biopsy results were: optic and immunoflu-
orescence microscopy normal.
EVOLUTIO.N
Auricular Chondritis
Arthritis
Nasal Chondritis
Ocular Manifestation
Larynx- Tracheal
Inner Ear
Cardiopathy
Vasculopathy
Nephropathy
Mc Adam
n = 159
88.60/0
81%
72.4%
65.4%
55.90/0
45.9%
11.9%
16.30/0
NR
Isaak
n = 112
85%
52%
540/0
51%
48%
43%
6%
14%
26%
Diagnosis of relapsing polychondritis (RP) was
made clinically on July 9, 1996, and treatment with
prednisone 1 mg/kg (60 mg per day) started. There was a
prompt subsidence of articular pain, fever and general
condition, with only hoarseness remaining.
The patient is now being followed up as an outpatient
receiving 40 mg of prednisone per day.
LITERATURE REVIEW
Epidemiology
The prevalence of RP is equal among men and
women. It has been described in all races but is more
frequent among Caucasians (17).
Clinical Findings (6-12)
RP is characterized by acute inflam~atory
episodes of cartilaginous structures that might recover
spontaneously, but that frequently relapse and
culminate with the destruction of its structure. It may
present systemic involvement with fever, weight loss,
and other organs such as central nervous system,
kidneys, respiratory tract, and blood vessels.
The most frequent clinical features of 2 literature
reviews with 159 and 112 cases were summarized by
Andres J Politi (Table 1).
The most frequent clinical feature in both series is
auricular chondritis. The auricular pavilion is swollen,
n = number of patients
painful and angry-red in colour. In 95% of cases it is
bilateral. It may provoke the narrowing of the external
auditive canal. The ear lobe is preserved. The process may
subside spontaneously, or it may destroy the cartilage,
leaving a "cabbage-like" appearance. It may present as a
poly or oligoarthritis.
Nasal chondritis leads to the destruction of the
cartilaginous portion of the nasal septum, giving the nose
a "saddle-like" appearance.
The ocular alterations are unspecific, such as
conjunctivitis, uveitis, retinopathies, optical neuritis,
palpebral edema, and proptosis. Episcleritis is the most
frequent, occurring in 39 per cent of cases (21).
Respiratory manifestations are hoarseness,
dyspnea, a choking sensation, wheezing, and pain in
the laryngotracheal articulations. These can provoke
obstruction through three mechanisms: edema of the
glottis, trachea and bronchi; formation of a fibrous mass
in the airways; and collapse of the tracheal cartilage.
The obstruction is complicated by infection.
Hearing loss may be experienced due to obstruction
of the external auditory canal, middle ear otitis, or by
affliction of the auditory branch of the VIII cranial nerve
due to vasculitis. Nausea, dizziness, vomiting, and ataxia
.by neuritis of the cochlear branch due to vasculitis may
also be present.
Vasculitis is also found in some cases of RP.
According to Michet, systemic vasculitis is the most
frequent associated inflammatory syndrome (17) but this
was not Politi's finding in his summary of 271 cases of
polychondritis (6). There are cases described of aortal and
mitral insufficiency, but these are rare.
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Associated Diseases
Complementary Exams
Table 2
Diseases associated with relapsing polychondritis
Approximately 25 percent ofRP cases are associated
with other diseases, with the following being the most
common according to Politi.
Etiopathogenesis
The etiopathogenesis is not clear, but there are indi-
cations of auto-immune involvement. RP is associated
with auto-immune diseases in 250/0 of cases; immunoglo-
bulins and lesion complements are encountered, as are
type II anticollagen antibodies in the serum of patients
with active RP. Clinical improvement occurs with immu-
nosuppression therapy.
Histopathology
The histopathological findings are diagnostic.
During the active phase, there is a loss of cartilage
metacromasis, chondral and perichondral necrosis,
infiltration by the polymorphonuclear neutrophils,
plasmacytes, lymphocytes, apoptotic bodies, and
perichondral hemorrhage. In the advanced stage, there is
cicatrical repair with lymphohistiocytic infiltration,
fibrosis, deposit of hemosiderin and loss of elastic tissue.
Studies with direct immunofluorescence revealed
positivity for IgA, IgM, IgG and C3, suggesting the
presence of circulating immune complexes (22,23).
Differential Diagnosis
Considering the general clinical situation, the most
difficult differential diagnosis is with Wegener's
granulomatosis (WG) and other systemic vasculitis. WG
is manifested as a systemic vasculitis with collapse of the
nasal wall, arthritis, and affliction of the respiratory
system. WG can be differentiated by the presence of
granulomas, involvement of lungs and kidneys, and the
lack of auricular pavilion involvement.
The "saddle" nose can also be found in WG and
leishmaniosis, advanced congenital syphilis, lupus,
sarcoidosis, the lepromatous type of leprosy, basocellular
epitheliomas, cocaine inhalation, aspergilosis and
paracocci di oi domi cosi s.
5%
3.1 %
1.25%
1.25%
1.25%
1.25%
5%
1.88%
1.25%
1.25%
0.62%
3.1%
6.9%
Rheumatoid Arthritis
Sjogren's Syndrome
Systemic Lupus Erithematous
Systemic Sclerodermia
Psoriatic Arthritis
Raynaud's Syndrome
Thyroiditis
Ulcerative Colitis
Glomerulonephritis
Disgammaglobulinemia
Pernicious Anemia
Neoplasm
Other
In a review of 129 patients with RP, 29 presented
affected kidneys. Mesangial expansion, cellular
proliferation, and necrotizing glomerulonephritis were
observed. Electron microscopy detected dense deposits
at the mesangi-al level, and direct immunofluorescence
revealed C3 and IgM in the mesangio (0).
Neurological manifestations include ophthalmic
neuritis of the oculomotor, facial and auditive-vestibular
neuritis, headaches, encephalopathy, convulsions,
hemiparesias and ataxias.
No complementary exam is diagnostic for RP; all
are only slightly sensitive and specific. Their utility is only
to discard other pathologies and recognize other ailments.
The erythrocyte sedimentation rate and reactive C
protein are the best exams to accompany the evolution of
the disease. Tadaki et al studied the composition of urinary
glucosaminoglican and found an elevation of dermatan
sulphate and hyaluronic acid, both of skin origin in the
active phases of the disease and not the 4-6 sulphate
condroi tin that would be expected in cases of cartilage
destruction (24). So further studies are necessary in this area.
AntiboVdies to type II collagen have been reported to
correlate with the activity of the disease (20).
Prognosis
The five-year survival rate is 74 per cent (14). The
most frequent reason for death is infection of the'
respiratory tract, secondary to the bronchial obstruction
and the use of corticosteriods. Other causes are systemic
vasculitis, acute respiratory insufficiency due to
respiratory collapse, and renal insufficiency due to
glomerulonephritis.
Treatment
The treatment of RP consists of the use of
nonsteriod anti-inflammatories and low dose
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corticosteroids in situations of mild auricular/nasal
chondritis or arthritis. For cases with serious
manifestations such as laryngotracheal or ocular
symptoms, inner ear inflammation, severe auricular or
nasal chondritis, systemic vasculitis, aortitis or
glomerulonephritis, prednisone at a dose of 1 mg/kg/
day is indicated. The use of immunosuppressors such
as azathioprine and cyclophosphoamide is reserved for
those patients refractory to steroid therapy (13). The use
of dapsona, colchicina (15), anti-CD4 monoclonal
antibody, D-penicillamine and antimalarials" has also
been described. The increasing number of successful
reports of cyclosporin A in a dose of 15 mg/kg/day
suggests that it may be the best tolerated and potentially
most reliable drug for the corticosteroid-resistant
patient (14,16). Nebulized racemic ephedrine is an option
used successfully in cases of acute subglotic edema (19).
Continuous positive airway pressure masks may
provide relief of severe dyspneic symptoms (17).
DISCUSSION
RP is a rare disease seldom described in the
literature. Only 500 cases have been published worldwide
up until now. In Brazil, only four articles were encountered
from 1990-96 (search by Lilacs).
Histological diagnosis is made with difficulty
because cartilage material cannot be obtained for analysis,
or because findings are uncharacteristic, principally in the
advanced stages when there is destruction of the structures
and their replacement by fibrosis. When there is no
possibility of a histological diagnosis, it must be made
clinically. According to Damiani and Levine, this clinical
diagnosis can be confirmed by:
1) Three of McAdam's criteria: bilateral auricular
chondritis, polychondritis, nasal chondritis,
ocular inflammation (conjunctivitis, scleritis,
episcleritis, uveitis or queratitis), chondritis of
the respiratory tract or involvement of the VII
cranial nerve, even without histological
confirmation;
2) One or more of McAdam's criteria with
histological confirmation;
3) Two or more affected sites with response to
treatment with corticoids or dapsona.
The case in question presents four of McAdam's
criteria: nasal chondritis, polychondritis, episceritis,
and chondritis of the respiratory tract, in addition to
the immediate response to corticotherapy. In spite of
not having histological confirmation, we were able to
make the diagnosis clinically. The hematuria with
negative dysmorphism and elevated urinary calcium
was interpreted as being due to urinary microcalculi,
which improves the prognosis.
The patient is being followed as an outclinic patient,
due to the possibility of relapses, renal involvement, and
airway obstruction, all of which would require rapid
intervention.
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